NN Investment Partners Holdings’s Abiomed Inc ABMD Stock Holding History

NN Investment Partners Holdings’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$970K	Buy	2,928 +452	+18%	+$139K	0.01%	651
2021 Q4	$890K	Buy	2,476 +580	+31%	+$196K	﹤0.01%	663
2021 Q3	$616K	Sell	1,896 -10,337	-85%	-$3.5M	﹤0.01%	692
2021 Q2	$3.82M	Sell	12,233 -28,767	-70%	-$8.82M	0.02%	456
2021 Q1	$13.1M	Sell	41,000 -5,200	-11%	-$1.66M	0.08%	223
2020 Q4	$15M	Sell	46,200 -8,600	-16%	-$2.38M	0.09%	192
2020 Q3	$15.2M	Buy	54,800 +2,603	+5%	+$750K	0.1%	179
2020 Q2	$12.6M	Buy	52,197 +2,948	+6%	+$592K	0.08%	190
2020 Q1	$7.15M	Buy	49,249 +39,552	+408%	+$6.57M	0.06%	261
2019 Q4	$1.65M	Buy	9,697 +46	+0.5%	+$8.53K	0.01%	525
2019 Q3	$1.72M	Buy	9,651 +2,312	+32%	+$500K	0.01%	494
2019 Q2	$1.91M	Buy	+7,339	New	+$1.95M	0.02%	471
2019 Q1	–	Sell	-6,613	Closed	-$2.15M	–	804
2018 Q4	$2.15M	Sell	6,613 -1,921	-23%	-$667K	0.02%	420
2018 Q3	$3.84M	Hold	8,534	–	–	0.03%	352
2018 Q2	$3.49M	Buy	+8,534	New	+$3.09M	0.03%	365

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

NN Investment Partners Holdings's ABMD Position: Q1 2022 in Review

NN Investment Partners Holdings increased its Abiomed Inc (ABMD) stake by 18% in Q1 2022, buying an estimated $139K and bringing the position to 2,928 shares worth $970K. The position accounts for 0.01% of the portfolio, ranked #651.

NN Investment Partners Holdings first reported a position in ABMD in Q2 2018 and has held it in 15 quarters since. The position peaked at $15.2M in Q3 2020. 500 funds tracked by Wall St. Rank hold ABMD as of Q1 2022.

NN Investment Partners Holdings held 2,928 shares of Abiomed Inc worth $970K as of Q1 2022.
NN Investment Partners Holdings bought 452 Abiomed Inc shares in Q1 2022, an estimated $139K.
Abiomed Inc made up 0.01% of NN Investment Partners Holdings's portfolio in Q1 2022, its #651 holding.
NN Investment Partners Holdings first reported a position in Abiomed Inc in Q2 2018 and has held it in 15 quarters since.
NN Investment Partners Holdings's Abiomed Inc position peaked at $15.2M in Q3 2020.
500 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2022.

Based on NN Investment Partners Holdings's 13F filing for Q1 2022, filed 11 May 2022.